Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

a-s medication solutions - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 200 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim oral suspension and other antibacterial drugs, sulfamethoxazole and trimethoprim oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. ac

Մալթա - անգլերեն - Medicines Authority

nutra essential otc, s.l. c/la granja 1-28108 alcobendas madrid , spain - oral suspension - ibuprofen 40 mg/ml - antiinflammatory and antirheumatic products

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

roche products (nz) ltd - sulfamethoxazole 40 mg/ml;  ; trimethoprim 8 mg/ml - syrup - 200/40mg per 5 ml - active: sulfamethoxazole 40 mg/ml   trimethoprim 8 mg/ml excipient: banana oil caramel carmellose sodium vanilla 73690/uh glycerol methyl hydroxybenzoate microcrystalline cellulose polysorbate 80 propyl hydroxybenzoate purified water saccharin sodium sorbitol

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - sulfamethoxazole 40 mg/ml; trimethoprim 8 mg/ml - oral suspension - 200mg,40mg/5ml - active: sulfamethoxazole 40 mg/ml trimethoprim 8 mg/ml

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - sulfamethoxazole 40 mg/ml;  ; trimethoprim 8 mg/ml;  ;  ;   - oral suspension - 200/40mg per 5 ml - active: sulfamethoxazole 40 mg/ml   trimethoprim 8 mg/ml       excipient: allura red ac carmellose sodium citric acid ethanol imitation cherry pfw 5000 1ou glycerol methyl hydroxybenzoate microcrystalline cellulose polysorbate 80 purified water saccharin sodium sodium benzoate sorbitol sunset yellow fcf

Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - sulfamethoxazole 40 mg/ml;  ;  ; trimethoprim 8 mg/ml;  ;  ;   - oral suspension - 200mg,40mg/5ml - active: sulfamethoxazole 40 mg/ml     trimethoprim 8 mg/ml       excipient: amaranth anise oil carmellose sodium dispersible cellulose ethanol licosoft alphapac 1206-r2- masks bitterness aniseed glycerol methyl hydroxybenzoate polysorbate 80 ponceau 4r purified water saccharin sodium sucrose

Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - sulfamethoxazole 200 mg; trimethoprim 40 mg - oral suspension - 40 mg - 200 mg/5 ml - sulfamethoxazole 40 mg/ml; trimethoprim 8 mg/ml - sulfamethoxazole and trimethoprim

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

state of florida doh central pharmacy - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 800 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella   species, enterobacter   species, morganella morganii , proteus mirabilis   and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. for the treatment of acute otitis

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

contract pharmacy services-pa - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 800 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella   species, enterobacter   species, morganella morganii , proteus mirabilis   and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. for the treatment of acute otitis

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

kaiser foundation hospitals - sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv), trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - sulfamethoxazole 400 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets, usp and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. urinary tract infections: for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli , klebsiella species, enterobacter species, morganella morganii , proteus mirabilis and proteus vulgaris . it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. ac